Shigellosis

Lancet. 2025 Oct 4;406(10511):1508-1519. doi: 10.1016/S0140-6736(25)01033-5. Epub 2025 Sep 4.

Abstract

Shigella is a Gram-negative, facultative intracellular, gastric acid-resistant bacterium of the Enterobacteriaceae family, which includes four serogroups: Shigella dysenteriae, Shigella sonnei, Shigella flexneri, and Shigella boydii. Globally, shigellosis is the most common cause of invasive bloody diarrhoea in children younger than 5 years. Humans are the only natural reservoir and an inoculum of only 10-100 organisms is required for infection. Rising antibiotic resistance rates increasingly reduce the ability to adequately treat severe disease. The prevention of infection with vaccination and sanitation strategies remains a crucial step in reducing worldwide morbidity and mortality.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Child
  • Child, Preschool
  • Dysentery, Bacillary* / diagnosis
  • Dysentery, Bacillary* / drug therapy
  • Dysentery, Bacillary* / epidemiology
  • Dysentery, Bacillary* / microbiology
  • Dysentery, Bacillary* / prevention & control
  • Global Health
  • Humans
  • Shigella Vaccines
  • Shigella* / classification
  • Shigella* / pathogenicity

Substances

  • Anti-Bacterial Agents
  • Shigella Vaccines